42494-458-30 : NDC 2026 Code

42494-458-30 : Entecavir Anhydrous ( Entecavir )

Additionally :

You can get information about “42494-458-30” NDC code in 42494-458-30 in HTML format

HTML | 42494-458-30 in TXT (Plain Text) format

TXT | 42494-458-30 in PDF (Portable Document Format)

PDF | 42494-458-30 in XML format

XML formats.

NDC Code : 42494-458-30 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "42494-458-30",
    "PackageDescription": "30 TABLET in 1 BOTTLE (42494-458-30) ",
    "NDC11Code": "42494-0458-30",
    "ProductNDC": "42494-458",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Entecavir",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Entecavir Anhydrous",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250515",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA216857",
    "LabelerName": "Cameron Pharmaceuticals",
    "SubstanceName": "ENTECAVIR ANHYDROUS",
    "StrengthNumber": "1",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-06-10",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250515",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}